高密度脂蛋白胆固醇水平与高危人群不良心血管结局的关联
这项前瞻性多中心队列研究纳入英国生物银行和Emory心血管生物银行的冠心病患者,发现极高HDL-C(>80 mg/dL)与全因死亡和心血管死亡风险升高相关,呈U型关联,且独立于HDL-C遗传风险评分。
要点
- 在冠心病患者中,HDL-C与死亡风险呈U型关联,极高HDL-C同样增加风险。
- HDL-C>80 mg/dL者全因死亡风险HR 1.96,心血管死亡风险HR 1.71。
- 该关联独立于已知HDL-C相关基因多态性,男性风险更高。
核心结论
- 在冠心病患者中,极高HDL-C水平(>80 mg/dL) paradoxically 与更高的全因死亡和心血管死亡风险相关。
- 该关联独立于与高HDL-C水平相关的常见基因多态性。
研究设计与样本
- UKB中位随访8.9年(IQR 8.0-9.7),EmCAB中位随访6.7年(IQR 4.0-10.8)。
主要发现
- 在UKB中,与HDL-C 40-60 mg/dL相比,>80 mg/dL者全因死亡风险HR 1.96(95%CI 1.42-2.71;P<.001),心血管死亡风险HR 1.71(95%CI 1.09-2.68;P=.02)。
- 上述结果在EmCAB中重复验证。
- UKB中调整HDL-C遗传风险评分后关联持续存在。
- UKB敏感性分析显示极高HDL-C组全因死亡风险男性HR 2.63(95%CI 1.75-3.95;P<.001),女性HR 1.39(95%CI 0.82-2.35;P=.23)。
临床怎么用
- 在冠心病患者中,HDL-C并非越高越好,极高水平(>80 mg/dL)应视为风险标志。
- 对HDL-C极高的冠心病患者,需加强风险评估与监测,而非单纯追求升高HDL-C。
局限性
- 研究为观察性队列,不能确立因果关系。
- 结果主要基于UKB和EmCAB人群,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Previous studies have shown lower cardiovascular risk with higher high-density lipoprotein cholesterol (HDL-C) levels. However, recent data in the general population have shown increased risk of adverse outcomes at very high HDL-C concentrations. OBJECTIVE: To study the association between very high HDL-C levels (>80 mg/dL) and mortality in patients with coronary artery disease (CAD) and to investigate the association of known HDL-C genotypes with high HDL-C level outcomes. DESIGN, SETTING, AND PARTICIPANTS: This prospective, multicenter, cohort study, conducted from 2006 to present in the UK and from 2003 to present in Atlanta, Georgia, recruited patients with CAD from the UK Biobank (UKB) and the Emory Cardiovascular Biobank (EmCAB), respectively. Patients without confirmed CAD were excluded from the study. Data analyses were conducted from May 10, 2020, to April 28, 2021. EXPOSURE: High HDL-C levels (>80 mg/dL). MAIN OUTCOMES AND MEASURES: The primary outcome was all-cause death. The secondary outcome was cardiovascular death. RESULTS: A total of 14 478 participants (mean [SD] age, 62.1 [5.8] years; 11 034 men [76.2%]) from the UKB and 5467 participants (mean [SD] age, 63.8 [12.3] years; 3632 men [66.4%]) from the EmCAB were included in the study. Over a median follow-up of 8.9 (IQR, 8.0-9.7) years in the UKB and 6.7 (IQR, 4.0-10.8) years in the EmCAB, a U-shaped association with outcomes was observed with higher risk in those with both low and very high HDL-C levels compared with those with midrange values. Very high HDL-C levels (>80 mg/dL) were associated with increased risk of all-cause death (hazard ratio [HR], 1.96; 95% CI, 1.42-2.71; P < .001) and cardiovascular death (HR, 1.71; 95% CI, 1.09-2.68; P = .02) compared with those with HDL-C levels in the range of 40 to 60 mg/dL in the UKB after adjustment for confounding factors. These results were replicated in the EmCAB. These associations persisted after adjustment for the HDL-C genetic risk score within the UKB. Sensitivity analyses demonstrated that the risk of all-cause mortality in the very high HDL-C group was higher among men than women in the UKB (HR, 2.63; 95% CI, 1.75-3.95; P < .001 vs HR, 1.39; 95% CI, 0.82-2.35; P = .23). CONCLUSIONS AND RELEVANCE: Results of this cohort study suggest that very high HDL-C levels are paradoxically associated with higher mortality risk in individuals with CAD. This association was independent of the common polymorphisms associated with high HDL-C levels.
引用
- Liu C, Dhindsa D, Almuwaqqat Z, et al. Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations. JAMA Cardiol. 2022. PMID: 35583863. doi:10.1001/jamacardio.2022.0912
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。